Tozorakimab: Syringe vs. Autoinjector Study

We are comparing how well Tozorakimab works when given through a prefilled syringe versus an autoinjector. This study aims to understand the differences in how the body absorbs the medication.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
PAREXEL International GmbH
#2601;Parexel Early Phase Unit Berlin
Berlin, Germany
Sponsor: AstraZeneca AB
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.